logo

For the Inventor, By the Inventor

Research Triangle Park, NC, United States of America

Michael Robert Peel

This inventor holds 8 USPTO granted patents and 1 published patent application and 6 EPO patents. Top assignees: Scynexis, Inc., Merck Sharp + Dohme Corp., Aerie Pharmaceuticals, Inc.. Active years: 2007-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Robert Peel. Retrieved from https://idiyas.com/inventor/michael-robert-peel-jncqbzp6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 50.0

 

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 60(Granted Patents)


Location History:

  • Research Triangle Park, NC (US) (2007 - 2015)
  • Chapel Hill, NC (US) (2008 - 2020)

Company Filing History:

goldMedal4 out of 19 
 
Scynexis, Inc.
 patents
silverMedal3 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal1 out of 60 
 
Aerie Pharmaceuticals, Inc.
 patents
4. 1 out of 1,169 
 
Glaxo Group Limited
 patents
5. 1 out of 47 
 
Msd K.k.
 patents
6. 1 out of 1 
 
Sentry Therapeutics Limited
 patent
where one patent can have more than one assignee

Years Active: 2007-2020

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 10738084 - Macrocycles (2020-08-11),
2. 9090671 - Macrocyclic peptides (2015-07-28),
3. 8614221 - Inhibitors of Akt activity (2013-12-24),
4. 8536114 - Macrocycles (2013-09-17),
5. 8222255 - Antifungal agents (2012-07-17),
6. 7863465 - Antifungal agents (2011-01-04),
7. 7470787 - Isoquinoline compounds (2008-12-30),
8. 7166597 - Fused pyrazole derivatives being protein kinase inhibitors (2007-01-23),

Title: The Innovative Contributions of Michael Robert Peel

Introduction

Michael Robert Peel is a notable inventor based in Research Triangle Park, NC (US). He holds a total of 8 patents, showcasing his significant contributions to the field of pharmaceuticals. His work primarily focuses on cyclic compounds and their applications in treating various medical conditions.

Latest Patents

Among his latest patents, one invention relates to macrocycles, which are cyclic compounds of a specific general formula. These compounds have potential uses as pharmaceuticals. Another significant patent involves macrocyclic peptides, specifically cyclosporine derivatives that are modified for enhanced efficacy. These derivatives are particularly aimed at treating the hepatitis C virus, highlighting Peel's commitment to addressing critical health issues.

Career Highlights

Throughout his career, Michael Robert Peel has worked with prominent companies such as Scynexis, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical research.

Collaborations

Michael has collaborated with several talented individuals in his field, including Weiming Fan and Ahmed Mamai. These partnerships have likely enriched his work and led to further innovations in his research.

Conclusion

Michael Robert Peel's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his dedication to innovation and improving healthcare solutions. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…